Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1988;78:10-14

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcken, D. E.
Right arrow Articles by Hickey, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcken, D. E.
Right arrow Articles by Hickey, A. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Mitral Valve Prolapse
*Mobility Aids

Circulation, Vol 78, 10-14, Copyright © 1988 by American Heart Association


ARTICLES

Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery

DE Wilcken and AJ Hickey
Department of Cardiovascular Medicine, University of New South Wales, Prince Henry Hospital, Sydney, Australia.

Severe mitral regurgitation requiring surgery is the most common life- threatening complication of mitral valve prolapse (MVP) and is due to progressive myxomatous change in the valve. We identified all residents of New South Wales, Australia, who had mitral valve surgery for myxomatous valve disease during 1982 and, using these data and the adult population statistics from 1982, estimated the cumulative risk of valve surgery in patients with MVP. In 1982, 50 of the 5.36 million New South Wales residents required surgery for this complication of MVP. Of the 50, 36 were men and 14 were women, which was significantly different from the population sex distribution (p less than 0.02) for mean age +/- SD of 60 +/- 11 years (range, 26-78 years). Using our previously determined 4% prevalence of adult MVP in New South Wales, we estimated the number of male and female patients with MVP at risk for each 5-year age interval and calculated age-specific event rates. The results show that the cumulative risk is minimal below the age of 50 years but then rises steeply, particularly in men. The risks in men aged 50, 60, and 70 years (with 95% confidence intervals) were 1:202 (130-448), 1:53 (37-82), and 1:28 (22-41), respectively. In women, the risk was less than half that in men (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
EuropaceHome page
H. Gunduz, H. Arinc, M. Kayardi, R. Akdemir, S. Ozyildirim, and C. Uyan
Heart rate turbulence and heart rate variability in patients with mitral valve prolapse
Europace, July 1, 2006; 8(7): 515 - 520.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
C. Kaymaz, N. Ozdemir, and M. Ozkan
Differentiating clinical and echocardiographic characteristics of chordal rupture detected in patients with rheumatic mitral valve disease and floppy mitral valve: impact of the infective endocarditis on chordal rupture
Eur J Echocardiogr, March 1, 2005; 6(2): 117 - 126.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. J. Grande-Allen, B. P. Griffin, N. B. Ratliff, D. M. Cosgrove III, and I. Vesely
Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 271 - 277.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. A. Freed, E. J. Benjamin, D. Levy, M. G. Larson, J. C. Evans, D. L. Fuller, B. Lehman, and R. A. Levine
Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1298 - 1304.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. J. Sutton and A. E. Weyman
Mitral Valve Prolapse Prevalence and Complications: An Ongoing Dialogue
Circulation, September 10, 2002; 106(11): 1305 - 1307.
[Full Text] [PDF]


Home page
NEJMHome page
L. A. Freed, D. Levy, R. A. Levine, M. G. Larson, J. C. Evans, D. L. Fuller, B. Lehman, and E. J. Benjamin
Prevalence and Clinical Outcome of Mitral-Valve Prolapse
N. Engl. J. Med., July 1, 1999; 341(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. J. Orencia, G. W. Petty, B. K. Khandheria, J. F. Annegers, D. J. Ballard, J. D. Sicks, W. M. O'Fallon, and J. P. Whisnant
Risk of Stroke With Mitral Valve Prolapse in Population-Based Cohort Study
Stroke, January 1, 1995; 26(1): 7 - 13.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. H. Cohn, G. S. Couper, S. F. Aranki, R. J. Rizzo, N. M. Kinchla, and J. J. Collins Jr.
Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 143 - 151.
[Abstract] [Full Text]